|Title||Under-Detection of Lyme Disease in Canada|
|Publication Type||Journal Article|
|Year of Publication||2018|
|Authors||Lloyd, VK, Hawkins, RG|
Causes of the discrepancies between reported cases and predicted actual cases may include undetected genetic diversity of Borrelia in Canada leading to failed serological detection of infection, failure to consider and initiate serological testing of patients, and failure to report clinically diagnosed acute cases. As these surveillance criteria are used to inform clinical and public health decisions, this under-detection will impact diagnosis and treatment of Canadian Lyme disease patients.